RIVERA DSR CAP

RIVERA DSR CAPSULES

Brand Name: RIVERA DSR
Molecules:

Rabeprazole Sodium (Enteric-Coated)
Domperidone (Sustained-Release)

Therapeutic Category: Proton Pump Inhibitor (PPI) & Prokinetic Agent
Dosage Form: Capsule
Packaging: Available in strips

Key Features:

Rabeprazole Sodium (Enteric-Coated): A proton pump inhibitor (PPI) that reduces stomach acid production by blocking the enzyme in the stomach wall responsible for acid secretion. The enteric coating ensures the drug is released in the intestine, protecting it from stomach acid.
Domperidone (Sustained-Release): A prokinetic agent that enhances gastrointestinal motility and reduces symptoms like nausea and vomiting. The sustained-release formulation ensures prolonged action.

Indications:

RIVERA DSR Capsules are indicated for:

⦁ Treatment of gastroesophageal reflux disease (GERD)
⦁ Management of acid-related disorders (e.g., peptic ulcers, gastritis)
⦁ Relief from symptoms like heartburn, bloating, and nausea
⦁ Improvement of gastrointestinal motility in conditions like gastroparesis

Advantages:

Combines the benefits of Rabeprazole and Domperidone for comprehensive management of acid-related and motility disorders.
Enteric-coated and sustained-release formulation ensures optimal efficacy and patient compliance.
Effective in reducing acid production and improving gastrointestinal motility.

Precautions:

Use only under medical supervision.
Not recommended for individuals with a history of hypersensitivity to Rabeprazole, Domperidone, or any other components.
Avoid in patients with severe liver impairment or known heart conditions.

Packaging:

Available in strips

Let’s Stay In Touch

Shopping cart

Gastro